Trans-omic analyses identified novel prognostic biomarkers for colorectal cancer survival
Clin Transl Med
.
2023 Jun;13(6):e1304.
doi: 10.1002/ctm2.1304.
Authors
Chanjuan Liu
1
2
,
Furong Yan
1
2
3
,
Dongli Song
2
4
,
Yiming Zeng
3
,
Tiankui Qiao
1
,
Duojiao Wu
1
2
,
Yunfeng Cheng
1
2
,
Hao Chen
5
Affiliations
1
Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
2
Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
3
Center of Molecular Diagnosis and Therapy, The Second Hospital of Fujian Medical University, Quanzhou, Fujian, China.
4
Shanghai Institute of Clinical Bioinformatics, Shanghai, China.
5
Department of Thoracic Surgery, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China.
PMID:
37329135
PMCID:
PMC10276188
DOI:
10.1002/ctm2.1304
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers, Tumor / genetics
Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / genetics
Humans
Prognosis
Substances
Biomarkers, Tumor
Grants and funding
20DZ2254300/Shanghai Engineering Research Center of Tumor Multi-Target Gene Diagnosis
ZK2019B30/Key Subject Construction Program of Shanghai Health Administrative Authority
82200043/National Natural Science Foundation of China
21ZR1459000/Science and Technology Commission of Shanghai Municipality
2018N008S/Quanzhou City Science & Technology Program of China